Nir Arbel
Corporate Officer/Principal chez EVOGENE LTD.
Fortune : - $ au 31/03/2024
Profil
Nir Arbel is the founder of Carmentix Pte Ltd.
He is currently working as the Chief Product Officer at Evogene Ltd.
He holds a doctorate degree from Ben-Gurion University of the Negev.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVOGENE LTD
-.--% | 17/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Nir Arbel
| Sociétés | Poste | Début |
|---|---|---|
| EVOGENE LTD. | Corporate Officer/Principal | 01/08/2021 |
Anciens postes connus de Nir Arbel
| Sociétés | Poste | Fin |
|---|---|---|
Carmentix Pte Ltd.
 Carmentix Pte Ltd. Packaged SoftwareTechnology Services Carmentix Pte Ltd. operates as a venture backed startup company developing a novel biomarker prognostic panel for pre term birth. It specializes in diagnostics, preterm birth and preeclampsia. The company was founded in 2015 and is headquartered in Singapore. | Chief Executive Officer | - |
Formation de Nir Arbel
| Ben-Gurion University of the Negev | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EVOGENE LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Carmentix Pte Ltd.
Carmentix Pte Ltd. Packaged SoftwareTechnology Services Carmentix Pte Ltd. operates as a venture backed startup company developing a novel biomarker prognostic panel for pre term birth. It specializes in diagnostics, preterm birth and preeclampsia. The company was founded in 2015 and is headquartered in Singapore. | Technology Services |
